Tyra Biosciences Inc (TYRA) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 23, 2024...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights PR Newswire CARLSBAD, Calif., May...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors

Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D...

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities